Patheon (TSX:PTI), a leading global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced a performance enhancement program and its results for the second quarter ended April 30, 2006. (All amounts are in U.S. dollars unless otherwise indicated.)
